trioxsalen 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 2759 | 3902-71-4 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Pigmenting photosensitizing agent obtained from several plants, mainly Psoralea corylifolia. It is administered either topically or orally in conjunction with ultraviolet light in the treatment of vitiligo.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 10 | mg | O |
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| July 24, 1964 | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | D05AD01 | DERMATOLOGICALS ANTIPSORIATICS ANTIPSORIATICS FOR TOPICAL USE Psoralens for topical use |
| ATC | D05BA01 | DERMATOLOGICALS ANTIPSORIATICS ANTIPSORIATICS FOR SYSTEMIC USE Psoralens for systemic use |
| FDA CS | M0017973 | Psoralens |
| MeSH PA | D003879 | Dermatologic Agents |
| MeSH PA | D017319 | Photosensitizing Agents |
| MeSH PA | D011838 | Radiation-Sensitizing Agents |
| FDA EPC | N0000175879 | Psoralen |
| CHEBI has role | CHEBI:47868 | photosensitising agent |
| CHEBI has role | CHEBI:50177 | dermatologic agent |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Vitiligo | indication | 56727007 | DOID:12306 |
| Photosensitivity | indication | 90128006 | |
| Skin Pigmentation Enhancement | indication |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Adenosine receptor A2a | GPCR | Ki | 6.13 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2C | GPCR | Ki | 5.91 | DRUG MATRIX | |||||
| Amine oxidase [flavin-containing] A | Enzyme | IC50 | 6.08 | DRUG MATRIX |
External reference:
| ID | Source |
|---|---|
| 4018884 | VUID |
| N0000147178 | NUI |
| D01034 | KEGG_DRUG |
| 4018884 | VANDF |
| C0041086 | UMLSCUI |
| CHEBI:28329 | CHEBI |
| CHEMBL1475 | ChEMBL_ID |
| DB04571 | DRUGBANK_ID |
| D014307 | MESH_DESCRIPTOR_UI |
| 5585 | PUBCHEM_CID |
| 2064 | INN_ID |
| Y6UY8OV51T | UNII |
| 10844 | RXNORM |
| 3061 | MMSL |
| 5637 | MMSL |
| d01436 | MMSL |
| 002021 | NDDF |
Pharmaceutical products:
None